Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Fatigue 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Brain Diseases 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 5Ketamine 3Standard of Care 2Methods 2Early Intervention, Educational 2Yoga 1Ultraviolet Therapy 1Self-Help Groups 1Psychotherapy, Group 1Psychotherapy 1Psychiatric Rehabilitation 1Propranolol 1Practice Guidelines as Topic 1N-Methyl-3,4-methylenedioxyamphetamine 1Mindfulness-Based Stress Reduction 1Midazolam 1Melatonin 1Meditation 1Interviews as Topic 1Exercise Therapy 1Educational Status 1Cognitive Behavioral Therapy 1Caregivers 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anxiety Disorders × Midazolam × Clear all
NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡